These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20121258)

  • 1. Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells.
    Das S; Shetty P; Valapala M; Dasgupta S; Gryczynski Z; Vishwanatha JK
    Biochemistry; 2010 Mar; 49(10):2216-26. PubMed ID: 20121258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer.
    Cui X; Zhang L; Luo J; Rajasekaran A; Hazra S; Cacalano N; Dubinett SM
    Oncogene; 2007 Jun; 26(29):4253-60. PubMed ID: 17237818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPI-C and STAT6 can cooperate to stimulate IgE germline transcription.
    Carlsson R; Thorell K; Liberg D; Leanderson T
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1155-60. PubMed ID: 16647686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling mechanisms, interaction partners, and target genes of STAT6.
    Hebenstreit D; Wirnsberger G; Horejs-Hoeck J; Duschl A
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):173-88. PubMed ID: 16540365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel Stat6 regulated proteins in IL-4-treated mouse lymphocytes.
    Tuomela S; Rautajoki KJ; Moulder R; Nyman TA; Lahesmaa R
    Proteomics; 2009 Feb; 9(4):1087-98. PubMed ID: 19180534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
    Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
    Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
    Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S
    Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
    Weng J; Ma W; Mitchell D; Zhang J; Liu M
    J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein TAF-Ibeta/SET.
    Anazawa Y; Nakagawa H; Furihara M; Ashida S; Tamura K; Yoshioka H; Shuin T; Fujioka T; Katagiri T; Nakamura Y
    Cancer Res; 2005 Jun; 65(11):4578-86. PubMed ID: 15930275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
    Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
    Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
    Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer.
    Griner NB; Young D; Chaudhary P; Mohamed AA; Huang W; Chen Y; Sreenath T; Dobi A; Petrovics G; Vishwanatha JK; Sesterhenn IA; Srivastava S; Tan SH
    Mol Cancer Res; 2015 Feb; 13(2):368-79. PubMed ID: 25344575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mRNA-binding site of annexin A2 resides in helices C-D of its domain IV.
    Aukrust I; Hollås H; Strand E; Evensen L; Travé G; Flatmark T; Vedeler A
    J Mol Biol; 2007 May; 368(5):1367-78. PubMed ID: 17395201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells.
    Zhang F; Zhang L; Zhang B; Wei X; Yang Y; Qi RZ; Ying G; Zhang N; Niu R
    J Proteome Res; 2009 Nov; 8(11):5041-7. PubMed ID: 19764771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration.
    Liu JW; Shen JJ; Tanzillo-Swarts A; Bhatia B; Maldonado CM; Person MD; Lau SS; Tang DG
    Oncogene; 2003 Mar; 22(10):1475-85. PubMed ID: 12629510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression.
    Schedel M; Frei R; Bieli C; Cameron L; Adamski J; Lauener R; Kabesch M
    J Allergy Clin Immunol; 2009 Sep; 124(3):583-9, 589.e1-6. PubMed ID: 19665768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.